Multivalent viral capsids with internal cargo for fibrin imaging

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Obermeyer, Allie C ^a   Capehart, Stacy L ^a   Jarman, John B ^a   Francis, Matthew B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; NANOPARTICLE; PEPTIDE; PROTEIN BINDING;

ARTICLE; BLOOD CLOTTING; CHEMICAL STRUCTURE; CONTROLLED STUDY; FIBRIN CLOT; FIBRIN FORMATION; FLUORESCENCE IMAGING; IN VITRO STUDY; MS2 VIRUS; NONHUMAN; OXIDATIVE COUPLING; PROTEIN BINDING; PROTEIN TARGETING; VIRUS CAPSID; VIRUS LIKE AGENT; CHEMISTRY; DIAGNOSTIC USE; LEVIVIRUS; METABOLISM; MOLECULAR IMAGING;

CAPSID; FIBRIN; LEVIVIRUS; MOLECULAR IMAGING; NANOPARTICLES; PEPTIDES; PROTEIN BINDING;

EID: 84903524886     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100678     Document Type: Article

References (65)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, et al. (2012) Heart Disease and Stroke Statistics-2012 Update A Report From the American Heart Association. Circulation 125: e2-e220. doi:10.1161/CIR.0b013e31823ac046.
2. Choudhury RP, Fuster V, Fayad ZA (2004) Molecular, cellular and functional imaging of atherothrombosis. Nat Rev Drug Discovery 3: 913-925. doi:10.1038/nrd1548. (Pubitemid 39529929)
3. Sanz J, Fayad ZA (2008) Imaging of atherosclerotic cardiovascular disease. Nature 451: 953-957. doi:10.1038/nature06803. (Pubitemid 351305938)
4. Choudhury RP, Fisher EA (2009) Molecular Imaging in Atherosclerosis, Thrombosis, and Vascular Inflammation. Arterioscler Thromb Vasc Biol 29: 983-991. doi:10.1161/ATVBAHA.108.165498.
5. McCarthy JR, Jaffer FA (2011) The role of nanomedicine in the imaging and therapy of thrombosis. Nanomedicine 6: 1291-1293. doi:10.2217/nnm.11.128.
6. McCarthy JR (2010) Nanomedicine and Cardiovascular Disease. Curr Cardiovasc Imaging Rep 3: 42-49. doi:10.1007/s12410-009-9002-3.
7. Chacko A-M, Hood ED, Zern BJ, Muzykantov VR (2011) Targeted nanocarriers for imaging and therapy of vascular inflammation. Curr Opin Colloid & Interface Sci 16: 215-227. doi:10.1016/j.cocis.2011.01.008.
8. Li D, Patel AR, Klibanov AL, Kramer CM, Ruiz M, et al. (2010) Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance. Circ Cardiovasc Imaging 3: 464-472. doi:10.1161/CIRCIMAGING.109.896654.
9. Kamaly N, Miller AD (2010) Paramagnetic Liposome Nanoparticles for Cellular and Tumour Imaging. Int J Mol Sci 11: 1759-1776. doi:10.3390/ ijms11041759.
10. Parrott MC, Benhabbour SR, Saab C, Lemon JA, Parker S, et al. (2009) Synthesis, Radiolabeling, and Bio-imaging of High-Generation Polyester Dendrimers. J Am Chem Soc 131: 2906-2916. doi:10.1021/ja8078175.
11. Lee CC, MacKay JA, Fréchet JMJ, Szoka FC (2005) Designing dendrimers for biological applications. Nature Biotechnol 23: 1517-1526. doi:10.1038/nbt1171. (Pubitemid 41752929)
12. McCarthy JR, Weissleder R (2008) Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 60: 1241-1251. doi:10.1016/j.addr.2008.03.014.
13. Jayagopal A, Russ PK, Haselton FR (2007) Surface Engineering of Quantum Dots for In Vivo Vascular Imaging. Bioconjugate Chem 18: 1424-1433. doi:10.1021/bc070020r. (Pubitemid 47464049)
14. Yildiz I, Shukla S, Steinmetz NF (2011) Applications of viral nanoparticles in medicine. Curr Opin Biotechnol 22: 901-908. doi:10.1016/j.copbio.2011.04.020.
15. Manchester M, Singh P (2006) Virus-based nanoparticles (VNPs): Platform technologies for diagnostic imaging. Adv Drug Deliv Rev 58: 1505-1522. doi:10.1016/j.addr.2006.09.014. (Pubitemid 44829893)
16. Lee LA, Wang Q (2006) Adaptations of nanoscale viruses and other protein cages for medical applications. Nanomedicine 2: 137-149. doi:10.1016/j.nano. 2006.07.009. (Pubitemid 44403221)
17. Li F, Zhang Z-P, Peng J, Cui Z-Q, Pang D-W, et al. (2009) Imaging viral behavior in Mammalian cells with self-assembled capsid-quantum-dot hybrid particles. Small 5: 718-726. doi:10.1002/smll.200801303.
18. Uchida M, Kosuge H, Terashima M, Willits DA, Liepold LO, et al. (2011) Protein Cage Nanoparticles Bearing the LyP-1 Peptide for Enhanced Imaging of Macrophage-Rich Vascular Lesions. ACS Nano 5: 2493-2502. doi:10.1021/nn102863y.
19. Kitagawa T, Kosuge H, Uchida M, Dua M, Iida Y, et al. (2012) RGD-Conjugated Human Ferritin Nanoparticles for Imaging Vascular Inflammation and Angiogenesis in Experimental Carotid and Aortic Disease. Molecular Imaging and Biology 14: 315-324. doi:10.1007/s11307-011-0495-1.
20. Terashima M, Uchida M, Kosuge H, Tsao PS, Young MJ, et al. (2011) Human ferritin cages for imaging vascular macrophages. Biomaterials 32: 1430-1437. doi:10.1016/j.biomaterials.2010.09.029.
21. Uchida M, Flenniken ML, Allen M, Willits DA, Crowley BE, et al. (2006) Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. J Am Chem Soc 128: 16626-16633. doi:10.1021/ja0655690. (Pubitemid 46032741)
22. Kickhoefer VA, Garcia Y, Mikyas Y, Johansson E, Zhou JC, et al. (2005) Engineering of vault nanocapsules with enzymatic and fluorescent properties. Proc Natl Acad Sci USA 102: 4348-4352. doi:10.1073/pnas.0500929102. (Pubitemid 40397114)
23. Pokorski JK, Hovlid ML, Finn MG (2011) Cell targeting with hybrid Qb virus-like particles displaying epidermal growth factor. ChemBioChem 12: 2441-2447. doi:10.1002/cbic.201100469.
24. Tong GJ, Hsiao SC, Carrico ZM, Francis MB (2009) Viral Capsid DNA Aptamer Conjugates as Multivalent Cell-Targeting Vehicles. J Am Chem Soc 131: 11174-11178. doi:10.1021/ja903857f.
25. Ashley CE, Carnes EC, Phillips GK, Durfee PN, Buley MD, et al. (2011) Cell-Specific Delivery of Diverse Cargos by Bacteriophage MS2 Virus-like Particles. ACS Nano 5: 5729-5745. doi:10.1021/nn201397z.
26. Plummer EM, Thomas D, Destito G, Shriver LP, Manchester M (2012) Interaction of cowpea mosaic virus nanoparticles with surface vimentin and inflammatory cells in atherosclerotic lesions. Nanomedicine 7: 877-888. doi:10.2217/nnm.11.185.
27. Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822.
28. Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505-510.
29. Kodadek T, Bachhawat-Sikder K (2006) Optimized protocols for the isolation of specific protein-binding peptides or peptoids from combinatorial libraries displayed on beads. Mol BioSyst 2: 25-35. doi:10.1039/b514349g.
30. Udugamasooriya DG, Dineen SP, Brekken RA, Kodadek T (2008) A peptoid "antibody surrogate" that antagonizes VEGF receptor 2 activity. J Am Chem Soc 130: 5744-5752. doi:10.1021/ja711193x. (Pubitemid 351600507)
31. Binz HK, Stumpp MT, Forrer P, Amstutz P, Plückthun A (2003) Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins. J Mol Biol 332: 489-503. (Pubitemid 37020959)
32. Binz HK, Amstutz P, Kohl A, Stumpp MT, Briand C, et al. (2004) High-affinity binders selected from designed ankyrin repeat protein libraries. Nat Biotechnol 22: 575-582. doi:10.1038/nbt962. (Pubitemid 38590636)
33. Hooker JM, Kovacs EW, Francis MB (2004) Interior Surface Modification of Bacteriophage MS2. J Am Chem Soc 126: 3718-3719. doi:10.1021/ja031790q. (Pubitemid 38391857)
34. Carrico ZM, Romanini DW, Mehl RA, Francis MB (2008) Oxidative coupling of peptides to a virus capsid containing unnatural amino acids. Chem Commun: 1205. doi:10.1039/b717826c.
35. Mastico RA, Talbot SJ, Stockley PG (1993) Multiple presentation of foreign peptides on the surface of an RNA-free spherical bacteriophage capsid. J Gen Virol 74 (Pt 4): 541-548. (Pubitemid 23113357)
36. Behrens CR, Hooker JM, Obermeyer AC, Romanini DW, Katz EM, et al. (2011) Rapid Chemoselective Bioconjugation through Oxidative Coupling of Anilines and Aminophenols. J Am Chem Soc 133: 16398-16401. doi:10.1021/ja2033298.
37. Wei B, Wei Y, Zhang K, Wang J, Xu R, et al. (2009) Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell-penetrating peptide. Biomed Pharmacother 63: 313-318. doi:10.1016/j.biopha.2008.07.086.
38. Laudano AP, Doolittle RF (1978) Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. Proc Natl Acad Sci USA 75: 3085-3089. (Pubitemid 8395123)
39. Pratt KP, Côté HC, Chung DW, Stenkamp RE, Davie EW (1997) The primary fibrin polymerization pocket: three-dimensional structure of a 30-kDa C-terminal gamma chain fragment complexed with the peptide Gly-Pro-Arg-Pro. Proc Natl Acad Sci USA 94: 7176-7181.
40. Yang Z, Mochalkin I, Doolittle RF (2000) A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. Proc Natl Acad Sci USA 97: 14156-14161. doi:10.1073/pnas.97. 26.14156. (Pubitemid 32016546)
41. Thakur ML, Pallela VR, Consigny PM, Rao PS, Vessileva-Belnikolovska D, et al. (2000) Imaging vascular thrombosis with 99mTc-labeled fibrin alpha-chain peptide. J Nucl Med 41: 161-168. (Pubitemid 30046698)
42. Aruva MR, Daviau J, Sharma SS, ThakurML (2006) Imaging thromboembolism with fibrin-avid 99mTc-peptide: evaluation in swine. J Nucl Med 47: 155-162. (Pubitemid 46768525)
43. McCarthy JR, Patel P, Botnaru I, Haghayeghi P, Weissleder R, et al. (2009) Multimodal Nanoagents for the Detection of Intravascular Thrombi. Bioconjugate Chem 20: 1251-1255. doi:10.1021/bc9001163.
44. Yu X, Song SK, Chen J, Scott MJ, Fuhrhop RJ, et al. (2000) High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med 44: 867-872.
45. Peter K, Graeber J, Kipriyanov S, Zewe-Welschof M, Runge MS, et al. (2000) Construction and functional evaluation of a single-chain antibody fusion protein with fibrin targeting and thrombin inhibition after activation by factor Xa. Circulation 101: 1158-1164. (Pubitemid 30146618)
46. Overoye-Chan K, Koerner S, Looby RJ, Kolodziej AF, Zech SG, et al. (2008) EP-2104R: A Fibrin-Specific Gadolinium-Based MRI Contrast Agent for Detection of Thrombus. J Am Chem Soc 130: 6025-6039. doi:10.1021/ja800834y. (Pubitemid 351620850)
47. Kolodziej AF, Nair SA, Graham P, McMurry TJ, Ladner RC, et al. (2012) Fibrin Specific Peptides Derived by Phage Display: Characterization of Peptides and Conjugates for Imaging. Bioconjugate Chem23: 548-556. doi:10.1021/bc200613e.
48. Hood CA, Fuentes G, Patel H, Page K, Menakuru M, et al. (2008) Fast conventional Fmoc solid-phase peptide synthesis with HCTU. J Pept Sci 14: 97-101. doi:10.1002/psc.921. (Pubitemid 351188095)
49. Wang L, Brock A, Herberich B, Schultz PG (2001) Expanding the Genetic Code of Escherichia coli. Science 292: 498-500. doi:10.1126/science.1060077. (Pubitemid 32335951)
50. Santoro SW, Wang L, Herberich B, King DS, Schultz PG (2002) An efficient system for the evolution of aminoacyl-tRNA synthetase specificity. Nat Biotechnol 20: 1044-1048. doi:10.1038/nbt742.
51. Comellas-Aragonès M, Sikkema FD, Delaittre G, Terry AE, King SM, et al. (2011) Solution scattering studies on a virus capsid protein as a building block for nanoscale assemblies. Soft Matter 7: 11380-11391. doi:10.1039/C1SM06123B.
52. Latallo ZS, Fletcher AP, Alkjaersig N, Sherry S (1962) Inhibition of fibrin polymerization by fibrinogen proteolysis products. Am J Physiol 202: 681-686.
53. Soon ASC, Lee CS, Barker TH (2011) Modulation of fibrin matrix properties via knob:hole affinity interactions using peptide-PEG conjugates. Biomaterials 32: 4406-4414. doi:10.1016/j.biomaterials.2011.02.050.
54. Watson JW, Doolittle RF (2011) Peptide-derivatized albumins that inhibit fibrin polymerization. Biochemistry 50: 9923-9927. doi:10.1021/bi201406c.
55. Nahrendorf M, Keliher E, Panizzi P, Zhang H, Hembrador S, et al. (2009) 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. JACC Cardiovasc Imaging 2: 1213-1222. doi:10.1016/j.jcmg.2009.04.016.
56. Sigal GB, Mammen M, Dahmann G, Whitesides GM (1996) Polyacrylamides Bearing Pendant α-Sialoside Groups Strongly Inhibit Agglutination of Erythrocytes by Influenza Virus: The Strong Inhibition Reflects Enhanced Binding through Cooperative Polyvalent Interactions. J Am Chem Soc 118: 3789-3800. doi:10.1021/ja953729u. (Pubitemid 26168538)
57. Gestwicki JE, Cairo CW, Strong LE, Oetjen KA, Kiessling LL (2002) Influencing receptor-ligand binding mechanisms with multivalent ligand architecture. J Am Chem Soc 124: 14922-14933. (Pubitemid 36014100)
58. Woller EK, Walter ED, Morgan JR, Singel DJ, Cloninger MJ (2003) Altering the Strength of Lectin Binding Interactions and Controlling the Amount of Lectin Clustering Using Mannose/Hydroxyl-Functionalized Dendrimers. J Am Chem Soc 125: 8820-8826. doi:10.1021/ja0352496. (Pubitemid 36886219)
59. Garimella PD, Datta A, Romanini DW, Raymond KN, Francis MB (2011) Multivalent, High-Relaxivity MRI Contrast Agents Using Rigid Cysteine-Reactive Gadolinium Complexes. J Am Chem Soc 133: 14704-14709. doi:10.1021/ja204516p.
60. Meldrum T, Seim KL, Bajaj VS, Palaniappan KK, Wu W, et al. (2010) A xenon-based molecular sensor assembled on an MS2 viral capsid scaffold. J Am Chem Soc 132: 5936-5937. doi:10.1021/ja100319f.
61. Farkas ME, Aanei IL, Behrens CR, Tong GJ, Murphy ST, et al. (2013) PET Imaging and Biodistribution of Chemically Modified Bacteriophage MS2. Mol Pharmaceutics 10: 69-76. doi:10.1021/mp3003754.
62. Hui KY, Haber E, Matsueda GR (1983) Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. Science 222: 1129-1132. (Pubitemid 14203781)
63. Knight LC, Maurer AH, Ammar IA, Shealy DJ, Mattis JA (1988) Evaluation of indium-111-labeled anti-fibrin antibody for imaging vascular thrombi. J Nucl Med 29: 494-502.
64. Laemmli UK (1970) Cleavage of Structural Proteins During the Assembly of the Head of Bacteriophage T4. Nature 227: 680-685.
65. Johnson P, Mihalyi E (1965) Physicochemical studies of bovine fibrinogen I. Molecular weight and hydrodynamic properties of fibrinogen and fibrinogen cleaved by sulfite in 5 M guanidine • HCl solution. Biochim Biophys Acta Biophys Incl Photosynth 102: 467-475. doi:10.1016/0926-6585(65)90137-8.